4-987877-A-G

Variant summary

Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5

The NM_000203.5(IDUA):​c.227A>G​(p.Tyr76Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000178 in 1,459,692 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: not found (cov: 33)
Exomes š‘“: 0.000018 ( 0 hom. )

Consequence

IDUA
NM_000203.5 missense

Scores

7
9
3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:3

Conservation

PhyloP100: 5.53
Variant links:
Genes affected
IDUA (HGNC:5391): (alpha-L-iduronidase) This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008]
SLC26A1 (HGNC:10993): (solute carrier family 26 member 1) This gene is a member of a family of sulfate/anion transporter genes. Family members are well conserved in their genomic (number and size of exons) and protein (aa length among species) structures, but have markedly different tissue expression patterns. This gene is primarily expressed in the liver, pancreas, and brain. Three splice variants that encode different isoforms have been identified. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_pathogenic. Variant got 7 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.951
PP5
Variant 4-987877-A-G is Pathogenic according to our data. Variant chr4-987877-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 552686.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=3, Pathogenic=1}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IDUANM_000203.5 linkc.227A>G p.Tyr76Cys missense_variant Exon 2 of 14 ENST00000514224.2 NP_000194.2 P35475-1
SLC26A1NM_022042.4 linkc.*956T>C 3_prime_UTR_variant Exon 3 of 3 ENST00000398516.3 NP_071325.2 Q9H2B4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IDUAENST00000514224.2 linkc.227A>G p.Tyr76Cys missense_variant Exon 2 of 14 2 NM_000203.5 ENSP00000425081.2 P35475-1
SLC26A1ENST00000398516 linkc.*956T>C 3_prime_UTR_variant Exon 3 of 3 1 NM_022042.4 ENSP00000381528.2 Q9H2B4-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD3 exomes
AF:
0.0000124
AC:
3
AN:
241606
Hom.:
0
AF XY:
0.00000759
AC XY:
1
AN XY:
131694
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000292
Gnomad ASJ exome
AF:
0.000204
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000178
AC:
26
AN:
1459692
Hom.:
0
Cov.:
30
AF XY:
0.0000207
AC XY:
15
AN XY:
726108
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.0000766
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000189
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.0000166
AC:
2

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:2Uncertain:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Mucopolysaccharidosis type 1 Pathogenic:1
Aug 06, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 76 of the IDUA protein (p.Tyr76Cys). This variant is present in population databases (rs780165694, gnomAD 0.02%). This missense change has been observed in individual(s) with mucopolysaccharidosis type I (PMID: 21394825, 25009127; Invitae). ClinVar contains an entry for this variant (Variation ID: 552686). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt IDUA protein function with a positive predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -

Mucopolysaccharidosis, MPS-I-S;C0086431:Mucopolysaccharidosis, MPS-I-H/S;C0086795:Hurler syndrome Pathogenic:1
Mar 08, 2024
Fulgent Genetics, Fulgent Genetics
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Uncertain:1
Mar 04, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: IDUA c.227A>G (p.Tyr76Cys) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 241606 control chromosomes. c.227A>G has been reported in the literature as a compound heterozygous genotype in at-least two individuals affected with Mucopolysaccharidosis type I (Scheie syndrome) and has been subsequently cited by others (example, Bertola_2011, Tylki-Szymanska_2010, Yu Lin_2015, Clarke_2019). These data indicate that the variant may be associated with disease. To our knowledge, no variant specific experimental evidence demonstrating an impact on protein function has been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. -

not provided Uncertain:1
Mar 17, 2021
Revvity Omics, Revvity
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Hurler syndrome Uncertain:1
Jun 30, 2017
Counsyl
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Pathogenic
0.41
D
BayesDel_noAF
Pathogenic
0.44
CADD
Pathogenic
29
DANN
Benign
0.93
DEOGEN2
Pathogenic
0.89
D
Eigen
Uncertain
0.52
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.94
D
M_CAP
Pathogenic
0.51
D
MetaRNN
Pathogenic
0.95
D
MetaSVM
Pathogenic
0.83
D
MutationAssessor
Uncertain
2.6
M
PrimateAI
Uncertain
0.71
T
PROVEAN
Uncertain
-4.3
D
REVEL
Pathogenic
0.84
Sift
Uncertain
0.0090
D
Sift4G
Uncertain
0.0040
D
Polyphen
1.0
D
Vest4
0.97
MutPred
0.72
Gain of loop (P = 0.1069);
MVP
0.98
MPC
0.85
ClinPred
0.95
D
GERP RS
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.44
gMVP
0.87

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs780165694; hg19: chr4-981665; API